Use of TMAs with concentration-based controls would bring further objectivity and standardization to tissue-based biomarker assays.

Tissue samples were analysed using the Tempus xT tumour normal assay, an NGS-based cancer genome profiling test that interrogates 648 cancer-related genes in tumour tissue with a matched normal ...

protein interactions and protein modifications in fixed cells and tissue samples. The Duolink ® immunoassay reagents are based on the in situ proximity ligation assay, capable of reporting ...

"For researchers conducting RNA-based assays, the quality of RNA within tissue samples is critical for obtaining accurate and reproducible results," says Vidyodhaya Sundaram, PhD, MBA, Vice ...

"GRAIL's ctDNA detection approach, which does not require tumor tissue ... (CDx) assays for use with AstraZeneca's therapies. GRAIL is committed to leveraging its blood-based methylation testing ...